国家卫生健康委员会
人民卫生出版社有限公司
2096-3947;EISSN 2414-6447
10-1495/R
季刊
个月
--------https://www.editorialmanager.com/glohj
《全球健康杂志(英文)(Global Health Journal)》期刊已被查看: 次
杂志社官网:http://www.keaipublishing.com/cn/journals/global-health-journal/
联系电话:010-59787183(官网电话)
投稿邮箱:ghj@pmph.com(官网邮箱)
主管单位:国家卫生健康委员会
主办单位:人民卫生出版社有限公司
地址:
邮编:
邮发:
全年定价:;欢迎广大学者朋友联系全球健康杂志(英文)(Global Health Journal)杂志社投稿订阅!
注意:本站并非《全球健康杂志(英文)(Global Health Journal)》杂志社官网,不提供征稿投稿服务,仅整理介绍该杂志内容!投稿请直接咨询杂志社!
1、投稿方式:在线投稿。
2、官网网址:
http://www.keaipublishing.com/cn/journals/global-health-journal/
投稿系统:https://www.editorialmanager.com/glohj
3、出刊日期:季刊,逢季末月30日出版。
2024年4月16日星期二
《全球健康杂志(英文)》简介
【微信公众号信息】
关于本刊
《全球健康杂志(英文)》(Global Health Journal, GHJ)是国家新闻出版署批准出版的正式医学专业学术期刊(CN:10-1495/R; ISSN:2096-3947)。由国家卫生健康委员会主管,人民卫生出版社有限公司主办并出版。目前为季刊,由我国公共卫生领域权威专家李立明教授担任主编。本刊已被Scopus和Directory of Open Access Journals (DOAJ)等国际数据库成功收录。GHJ云集世界权威专家资源和健康领域精粹,立足高视角、高起点、高水准,深入而全面地探讨全球健康的主要挑战、应对全球健康管理问题、并为全球健康在观念和治理方面的创新指引航向。力求打造成为传播全球健康信息,交流全球健康经验,推广全球健康成果的国际出版平台。主要议题含括公共卫生、重大疾病防控、健康卫生体制和政策、社会疾病负担、老龄化与老年病、健康治理和健康促进、全球卫生外交、精神健康、生殖健康、传染性疾病、慢病防控、环境健康、妇幼保健、营养与食品安全、国际卫生合作、医疗服务、劳动卫生等具有全球意义的健康议题以及健康决定因素等。读者对象为联合国相关机构、卫生行政主管单位、健康产业相关人员、卫生政策制定相关单位及研究人员、高等医学院校相关专业人员、医疗卫生学术团体和研究机构、各类医疗卫生单位以及其他关注“全球健康”领域的人员。
《全球健康杂志(英文)》投稿指南
【官网信息】
Guide for Authors
INTRODUCTION
Types of paper
Contributions falling into the following categories will be considered for publication: [ research articles, reviews, health policy, short communications,editorials, commentaries, letters, perspectives, window for China, bridging Belt and Road countries ].
Please ensure that you select the appropriate article type from the list of options when making your submission. Authors contributing to special issues should ensure that they select the special issue article type from this list.
BEFORE YOU BEGIN
For information on Ethics in Publishing and Ethical guidelines for journal publication see https://www.elsevier.com/publishingethics and https://www.elsevier.com/ethicalguidelines
Ethics approval and consent to participate
Manuscripts reporting studies involving human participants, human data or human tissue must:
include a statement on ethics approval and consent (even where the need for approval was waived)
include the name of the ethics committee that approved the study and the committee's reference number if appropriate
All materials must adhere to high ethical and animal welfare standards. Any use of animals must be based on ethological knowledge and respect for species-specific requirements for health and well-being. A statement indicating that the protocol and procedures employed were ethically reviewed and approved, and the name of the body giving approval, must be included in the Methods section of the manuscript.
Consent for publication:
If your research or manuscript contains any individual person's data in any form (including any individual details, images or videos), consent for publication must be obtained from that person, or in the case of children, their parent or legal guardian. All presentations of case reports must have consent for publication.
Competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors should complete the declaration of competing interest statement using https://www.elsevier.com/declaration-of-competing-interests and upload to the submission system at the Attach/Upload Files step. Note: Please do not convert the .docx template to another file type. Author signatures are not required. If there are no interests to declare, please choose the first option in the template. More Information https://service.elsevier.com/app/answers/detail/a_id/286/supporthub/publishing/
Submission declaration
Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere including electronically in the same form, in English or in any other language, without the written consent of the copyright-holder.
CRediT author statement
For transparency, all authors are requested to submit an author statement file outlining their individual contributions to the paper using the relevant CRediT roles : Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administration; Resources; Software; Supervision; Validation; Visualization; Roles/Writing - original draft; Writing - review and editing. Authorship statements should be formatted with the names of authors first and CRediT role(s) following. More details and example https://www.elsevier.com/authors/journal-authors/policies-and-ethics/credit-author-statement
Changes to authorship
This policy concerns the addition, deletion, or rearrangement of author names in the authorship of accepted manuscripts:
Before the accepted manuscript is published: Requests to add or remove an author, or to rearrange the author names, must be sent to the Journal Manager from the corresponding author of the accepted manuscript and must include: (a) the reason the name should be added or removed, or the author names rearranged and (b) written confirmation (e-mail, fax, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Requests that are not sent by the corresponding author will be forwarded by the Journal Manager to the corresponding author, who must follow the procedure as described above. Note that: (1) Journal Managers will inform the Journal Editors of any such requests and (2) publication of the accepted manuscript in an online issue is suspended until authorship has been agreed.
After the accepted manuscript is published: Any requests to add, delete, or rearrange author names in an article published in an online issue will follow the same policies as noted above and result in a corrigendum.
……
更多详情:
https://www.keaipublishing.com/en/journals/global-health-journal/guide-for-authors/
全球健康杂志(英文)(Global Health Journal)杂志被以下数据库收录:
主办上海市卫生和健康发展研究中心(上海市医学科学技术情报研究所)级别:北核,科核,CSCD扩,武A-,CACJ-核心
影响因子:2.389
主办中华医学会级别:CSCD,科核
影响因子:0.907
主办上海市疾病预防控制中心级别:北核,CSCD,科核,高T3,武B+
影响因子:1.403
主办中华医学会、上海市计划生育科学研究所、复旦大学附属妇科医院级别:CSCD
影响因子:0
主办浙江大学级别:CSCD
影响因子:0
主办中华医学会级别:CSCD
影响因子:0
主办融通医健期刊出版(北京)有限公司主办级别:科核,武B+
影响因子:0.703
主办军事医学科学院卫生学环境医学研究所级别:武B+
影响因子:0.955
杂志社官网:http://www.keaipublishing.com/cn/journals/global-health-journal/
联系电话:010-59787183(官网电话)
投稿邮箱:ghj@pmph.com(官网邮箱)
全球健康杂志(英文)(Global Health Journal)不是核心期刊,级别是:国级普刊, 是:分类下的万方,维普,万方目次收录的期刊。
我们不是《全球健康杂志(英文)(Global Health Journal)》杂志社。本站主要从事期刊信息展示与期刊推荐,不是任何杂志官网,直投稿件请联系杂志社。本站仅提供免费的学术指导、论文辅导、期刊投稿信息整理收集服务。
期刊发表的成功与否,主要取决于文章内容的质量。编辑老师会根据研究领域、创新性等多因素进行考量。优化投稿流程,避免频繁碰壁,缩短发表周期,节省您的宝贵时间,让您的学术成果快速发表
ChatGPt在科学论文写作中的潜在应用、实际效果以及面临的挑战与极限性。至于,Sci论文能用ChatGPt写吗?能用,但要注意ChatGPt写论文面临的挑战和
评职称用的正规课题材料申请流程就收到了相关主管部门下发的课题申报红头文件,然后开始执笔撰写申报材料,写好之后提交到单位科研科领导审核通过之后,单位就会帮你依托单位提交到相关部门去申报,申报公示立项,这是课题申报的流程。